文献速递神经肿瘤

新诊断世界卫生组织1级脑膜瘤全切除后复发的基因表达变化

Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma.
PubMed 文献 · Neurosurgery · 2024-08-05

这项回顾性国际多中心队列研究纳入442例新诊断WHO 1级脑膜瘤且全切除的患者,评估34基因panel表达与复发的关系。中位随访5.0年,局部复发36例(8.1%),5年局部无复发生存率为90.5%。11个基因与局部复发相关,基于这些基因的K-means聚类区分出2个分子亚组,局部无复发生存差异有统计学意义(HR 2.5,95%CI 1.2-5.1,P=.016)。

要点

  • WHO 1级脑膜瘤全切除后中位随访5.0年,局部复发36例(8.1%),5年局部无复发生存率90.5%。
  • 11个基因与局部复发相关,PGK1效应量最大。
  • 基于11基因的K-means聚类分出2个分子亚组,局部无复发生存差异有统计学意义(HR 2.5,95%CI 1.2-5.1,P=.016)。

核心结论

  • 基因表达谱可能有助于识别尽管全切除但复发风险升高的新诊断WHO 1级脑膜瘤。

研究设计与样本

  • 回顾性、国际、多中心队列研究,纳入基于术后磁共振成像确认全切除且为首诊治疗的WHO 1级脑膜瘤患者。
  • 共442例患者纳入分析,采用既往验证的34基因panel的标准化基因表达值评估与复发的关联。
  • 统计方法包括Kaplan-Meier分析、多变量Cox比例风险分析和K-means聚类。

主要发现

  • 中位随访5.0年(四分位距2.6-7.7年),局部复发36例(8.1%),5年局部无复发生存率90.5%,中位复发时间2.9年(范围0.5-10.7年)。
  • 11个基因与局部复发相关:ARID1B、ESR1、LINC02593、PGR和TMEM30B表达较低,CDK6、CDKN2C、CKS2、KIF20A、PGK1和TAGLN表达较高。
  • 在这些基因中,PGK1的效应量最大。
  • 基于11个基因的K-means聚类将临床和组织学低风险脑膜瘤分为2个分子组,局部无复发生存差异有统计学意义(HR 2.5,95%CI 1.2-5.1,P=.016)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Patients who undergo gross total resection (GTR) of Central Nervous System World Health Organization (WHO) grade 1 meningioma constitute a "low-risk" group, but some low-risk meningiomas can recur despite reassuring clinical and histological features. In this study, gene expression values in newly diagnosed WHO grade 1 meningiomas that had undergone GTR were evaluated for their association with recurrence. METHODS: This was a retrospective, international, multicenter cohort study that included WHO grade 1 meningiomas that underwent GTR, as first treatment, based on postoperative magnetic resonance imaging. Normalized gene expression values from a previously validated 34-gene panel were evaluated for their association with recurrence. Kaplan-Meier, multivariable Cox proportional hazard analyses, and K-means clustering were performed to assess the association of genes of interest with recurrence and identify molecular subgroups among clinically and histologically low-risk meningiomas. RESULTS: In total, 442 patients with WHO grade 1 meningiomas that underwent GTR and had available gene expression profiling data were included in the study. The median follow-up was 5.0 years (interquartile range 2.6-7.7 years), local recurrence occurred in 36 patients (8.1%), 5-year local freedom from recurrence was 90.5%, and median time to recurrence was 2.9 years (range 0.5-10.7 years). Eleven genes were associated with local recurrence, including lower expression of ARID1B , ESR1 , LINC02593 , PGR , and TMEM30B and higher expression of CDK6 , CDKN2C , CKS2 , KIF20A , PGK1 , and TAGLN . Of these genes, PGK1 had the largest effect size. K-means clustering based on these 11 genes distinguished 2 molecular groups of clinically and histologically low-risk meningiomas with significant differences in local freedom from recurrence (hazard ratio 2.5, 95% CI 1.2-5.1, P = .016). CONCLUSION: Gene expression profiling may help to identify newly diagnosed WHO grade 1 meningiomas that have an elevated risk of recurrence despite GTR.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Morshed RA, Nguyen MP, Youngblood MW, et al. Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma. Neurosurgery. 2024. PMID: 39101743. doi:10.1227/neu.0000000000003133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。